FluMos-v2

FluMos-v2 mosaic hexavalent influenza vaccine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FluMos-v2, covering 2026-01-06 to 2026-01-06. Get the full timeline:

Most recent: Clinical Trial Update: Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adults [Phase 1]

See pricing